江西同和药业股份有限公司
Jiangxi Synergy Pharmaceutical Co. Ltd.
Country: CN CDE+DMF+CEP VERY_HIGH
🇨🇳 CDE
20
22 products shown
🇺🇸 DMF
24
24 products shown
🇪🇺 CEP
10
10 products shown
Total
54
registrations
🇨🇳 CDE 注册 (22)
| Product | CAS | Status | Reg Number |
|---|---|---|---|
| Agomelatine 阿戈美拉汀 | 138112-76-2 | Class A | Y20220000795 |
| Apixaban 阿哌沙班 | 503612-47-3 | Class A | Y20200001005 |
| Azilsartan Medoxomil Potassium MY008211A | 863031-21-4 | Class A | Y20220001325 |
| Canagliflozin 卡格列净 | 842133-18-0 | Class I | Y20240000412 |
| Celecoxib 塞来昔布 | 169590-42-5 | Class A | Y20240001113 |
| Celecoxib 塞来昔布 | 169590-42-5 | Class A | Y20180000172 |
| Crisaborole 克立硼罗 | 906673-24-3 | Class A | Y20220001177 |
| Edoxaban Tosylate 甲苯磺酸艾多沙班 | 480449-70-5 | Class A | Y20240000672 |
| Edoxaban Tosylate 甲苯磺酸艾多沙班 | 480449-70-5 | Class A | Y20200001211 |
| Empagliflozin 恩格列净 | 864070-44-0 | Class A | Y20220001013 |
| Febuxostat 非布司他 | 144060-53-7 | Class A | Y20200001229 |
| Gabapentin 加巴喷丁 | 60142-96-3 | Class A | Y20200001004 |
| Mirabegron 米拉贝隆 | 223673-61-8 | Class A | Y20200001228 |
| Rebamipide 瑞巴派特 | 90098-04-7 | Class A | Y20210000488 |
| Relugolix 瑞卢戈利 | 737789-87-6 | Class I | Y20230000852 |
| Rivaroxaban 利伐沙班 | 366789-02-8 | Class A | Y20200000624 |
| Roxadustat 罗沙司他 | 808118-40-3 | Class A | Y20240001574 |
| Ticagrelor 替格瑞洛 | 274693-27-5 | Class A | Y20180000483 |
| Venlafaxine 文拉法辛 | - | Class A | Y20190007362 |
| Vicagrel 维卡格雷 | 1314081-53-2 | Class I | Y20230000853 |
| Vildagliptin 维格列汀 | 274901-16-5 | Class A | Y20200000604 |
| Vonoprazan 富马酸伏诺拉生 | 881681-00-1 | Class A | Y20240000857 |
🇺🇸 DMF 注册 (24)
| Product | CAS | DMF Number | Date |
|---|---|---|---|
| Aceclofenac 醋氯芬酸 | 89796-99-6 | 24210 | 2010-09-24 |
| Apixaban 阿哌沙班 | 503612-47-3 | 32781 | 2018-04-21 |
| Azilsartan 阿齐沙坦 | 147403-03-0 | 40433 | 2024-09-17 |
| Azilsartan Kamedoxomil 阿齐沙坦 | 863031-24-7 | 37693 | 2024-06-28 |
| Canagliflozin Hemihydrate 卡格列净 | 928672-86-0 | 38734 | 2023-09-27 |
| Candesartan Cilexetil 坎地沙坦酯 | 139481-59-7 | 23649 | 2010-03-18 |
| Celecoxib 塞来昔布 | 169590-42-5 | 25582 | 2011-08-16 |
| Crisaborole 克立硼罗 | 906673-24-3 | 40025 | 2024-05-30 |
| Dabigatran Etexilate Mesylate 甲磺酸达比加群酯（微粉） | 211915-06-9 | 32782 | 2018-04-21 |
| Dapagliflozin (amorphous) 达格列净 | 461432-26-8 | 39975 | 2024-06-05 |
| Edoxaban Tosilate 依度沙班 | 480449-71-6 | 38513 | 2023-09-20 |
| Empagliflozin 恩格列净 | 864070-44-0 | 37622 | 2022-11-02 |
| Febuxostat 非布司他 | 144060-53-7 | 32780 | 2018-04-21 |
| Gabapentin 加巴喷丁 | 60142-96-3 | 25825 | 2012-02-22 |
| Gabapentin (e) 加巴喷丁 | 60142-96-3 | 34315 | 2020-01-07 |
| Mirabegron 米拉贝隆 | 223673-61-8 | 31661 | 2017-04-05 |
| Opicapone 奥吡卡朋 | 923287-50-7 | 42988 | 2025-11-24 |
| Rebamipide 瑞巴派特 | 90098-04-7 | 21700 | 2008-06-09 |
| Rivaroxaban 利伐沙班 | 366789-02-8 | 31601 | 2017-03-16 |
| Roxadustat 罗沙司他 | 808118-40-3 | 42830 | 2025-11-24 |
| Telmisartan 替米沙坦 | 144701-48-4 | 24211 | 2010-09-24 |
| Ticagrelor 替格瑞洛 | 274693-27-5 | 31620 | 2017-03-24 |
| Vildagliptin 维格列汀 | 274901-16-5 | 31663 | 2017-04-05 |
| Vonoprazan Fumarate 富马酸伏诺拉生 | 881681-01-2 | 39360 | 2024-05-16 |
🇪🇺 CEP 注册 (10)
| Product | CAS | CEP Number | Date |
|---|---|---|---|
| Aceclofenac 醋氯芬酸 | 89796-99-6 | R1-CEP 2013-274 - Rev 01 | 2021-07-20 |
| Candesartan Cilexetil 坎地沙坦酯 | 139481-59-7 | CEP 2013-007 - Rev 05 | 2025-06-25 |
| Celecoxib 塞来昔布 | 169590-42-5 | R1-CEP 2012-404 - Rev 00 | 2019-07-04 |
| Celecoxib, Process II 塞来昔布 | 169590-42-5 | CEP 2024-468 - Rev 00 | 2025-02-04 |
| Gabapentin 加巴喷丁 | 60142-96-3 | R1-CEP 2011-264 - Rev 00 | 2017-10-25 |
| Gabapentin, Process II 加巴喷丁 | 60142-96-3 | CEP 2019-343 - Rev 03 | 2025-04-10 |
| Mirabegron 米拉贝隆 | 223673-61-8 | CEP 2023-180 - Rev 02 | 2024-10-30 |
| Rivaroxaban 利伐沙班 | 366789-02-8 | CEP 2021-047 - Rev 02 | 2024-11-13 |
| Telmisartan 替米沙坦 | 144701-48-4 | R1-CEP 2013-135 - Rev 00 | 2020-09-17 |
| Ticagrelor 替格瑞洛 | 274693-27-5 | CEP 2021-303 - Rev 01 | 2025-09-12 |
Source: cde+fda_direct; DMF高置信 | Updated: 2026-09-11 06:00:12